Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19

Bo Yu, Chenze Li, Peng Chen, +5

Science China Life Sciences

Critical Care ManagementCritical Care MedicineIll PatientsLow DoseCovid-19 Pandemic +7

Decreased serum albumin level indicates poor prognosis of COVID-19 patients: hepatic injury analysis from 2,623 hospitalized cases

Wei Huang, Chenze Li, Zhiquan Wang, +6

Science China Life Sciences

Hepatic DisordersHepatologyLiver PhysiologyPathologyLaboratory Medicine +9

Modeling the oxidation kinetics of sono-activated persulfate’s process on the degradation of humic acid

Songlin Wang, Ning Zhou, Si Wu, +2

Ultrasonics Sonochemistry

Effects of Heart Rate and Anesthetic Timing on High-Resolution Echocardiographic Assessment Under Isoflurane Anesthesia in Mice

Jian Wu, Liping Bu, Hui Gong, +11

Journal of Ultrasound in Medicine

Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients

Chenze Li, Jiangang Jiang, Feng Wang, +5

Journal of Molecular and Cellular Cardiology

Inhibition of SRF/myocardin reduces aortic stiffness by targeting vascular smooth muscle cell stiffening in hypertension

Ning Zhou, Jia‐Jye Lee, Shaunrick Stoll, +5

Cardiovascular Research

Hydroxychloroquine application is associated with a decreased mortality in critically ill patients with COVID-19

Bo Yu, Chenze Li, Peng Chen, +5

Ill PatientsOral HydroxychloroquineNhcq TreatmentsCovid-19Critical Care Medicine +15

A life support-based comprehensive treatment regimen dramatically lowers the in-hospital mortality of patients with fulminant myocarditis: a multiple center study

Sheng Li, Shengyong Xu, Chenze Li, +12

Science China Life Sciences

Heart FailureEnd-of-life CareFulminant MyocarditisMultiple Center StudyOutcomes Research +6

Ryanodine Receptor Type 2 Is Required for the Development of Pressure Overload-Induced Cardiac Hypertrophy

Yunzeng Zou, Yanyan Liang, Hui Gong, +16

Hypertension

Molecular PharmacologyCardiomyopathyHeart FailureMolecular PhysiologySignal Transduction +13

Qiliqiangxin Inhibits the Development of Cardiac Hypertrophy, Remodeling, and Dysfunction During 4 Weeks of Pressure Overload in Mice

Yunzeng Zou, Lin Li, Yong Ye, +11

Journal of Cardiovascular Pharmacology

Cardiac MuscleHypertensionHeart FailureCardiovascular PharmacologyPathology +26